Replimune Group (REPL)
(Delayed Data from NSDQ)
$11.31 USD
-0.10 (-0.88%)
Updated Oct 17, 2024 03:59 PM ET
After-Market: $11.30 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Replimune Group, Inc. (REPL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$15.50 | $17.00 | $13.00 | 37.05% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for Replimune Group, Inc. comes to $15.50. The forecasts range from a low of $13.00 to a high of $17.00. The average price target represents an increase of 37.05% from the last closing price of $11.31.
Analyst Price Targets (8 )
Broker Rating
Replimune Group, Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on 10 recommendations.
Of the eight recommendations deriving the current ABR, eight are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 9 | 10 | 9 | 9 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/15/2024 | BMO Capital Markets | Evan Seigerman | Strong Buy | Strong Buy |
9/10/2024 | H.C. Wainwright & Co. | Robert Burns | Strong Buy | Strong Buy |
5/21/2024 | Piper Sandler | Allison M Bratzel | Strong Buy | Strong Buy |
5/17/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/16/2024 | SVB Securities | Jonathan W Chang | Strong Buy | Strong Buy |
5/16/2024 | Wedbush Securities | Robert Driscoll | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 8 |
Average Target Price | $15.50 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 88 of 252 |
Current Quarter EPS Est: | -0.75 |
REPL FAQs
Replimune Group, Inc. (REPL) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for Replimune Group, Inc. (REPL) is $15.50. The current on short-term price targets is based on 6 reports.
The forecasts for Replimune Group, Inc. (REPL) range from a low of $13 to a high of $17. The average price target represents a increase of $37.05 from the last closing price of $11.31.
The current UPSIDE for Replimune Group, Inc. (REPL) is 37.05%
Based on short-term price targets offered by eight analysts, the average price target for Replimune Group, Inc. comes to $15.50. The forecasts range from a low of $13.00 to a high of $17.00. The average price target represents an increase of 37.05% from the last closing price of $11.31.